New Drug Shows Promise for Resistant Thyroid Cancer
Lenvatinib shrunk tumors in 65 percent of those taking the drug, according to late-stage researchContinue Reading
Lenvatinib shrunk tumors in 65 percent of those taking the drug, according to late-stage researchContinue Reading
Preliminary findings suggest this experimental treatment might slow diseaseContinue Reading
But experts debate significance of this expensive treatmentContinue Reading
Indoor tanning increases the risk of skin cancer, experts sayContinue Reading
When added to chemotherapy, it also boosted survival rates, researchers reportContinue Reading
They didn’t die sooner, had better quality of life than those who kept taking cholesterol drugs, researchers sayContinue Reading
Researchers find chances double for those with the mental illness, but their rates of cancer are lowerContinue Reading
Odds for deadly skin cancer rise 80 percent, nurses’ study findsContinue Reading
Researchers target genetic mutations common among uveal melanoma patientsContinue Reading
Seeing smokeless devices in action triggered urge for a regular cigarette in young smokers, study foundContinue Reading
All sunlamp devices must warn against use by people under 18, agency saysContinue Reading
Researchers find bad news motivates many to quit tobaccoContinue Reading
But findings still preliminary, need confirmationContinue Reading
Expert warns against trying for a pre-summer glowContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.